Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Sarcoma 1Other solid neoplasm 1NET 1Endocrine 1Dermatologic 1

Conditions

Colorectal Neoplasms 325Pancreatic Neoplasms 189Carcinoma, Hepatocellular 119Stomach Neoplasms 116Colonic Neoplasms 87Esophageal Neoplasms 85Carcinoma, Non-Small-Cell Lung 84Breast Neoplasms 80Rectal Neoplasms 78Ovarian Neoplasms 65Neoplasm Metastasis 61Lung Neoplasms 61Neoplasms 57Cholangiocarcinoma 55Liver Neoplasms 47Melanoma 46Gastrointestinal Neoplasms 46Prostatic Neoplasms 43Biliary Tract Neoplasms 37Endometrial Neoplasms 34Squamous Cell Carcinoma of Head and Neck 32Sarcoma 32Carcinoma, Renal Cell 30Esophageal Squamous Cell Carcinoma 28Uterine Cervical Neoplasms 27Head and Neck Neoplasms 25Adenocarcinoma Of Esophagus 24Urinary Bladder Neoplasms 23Small Cell Lung Carcinoma 20Triple Negative Breast Neoplasms 17

Interventions

pembrolizumab 1fludarabine phosphate 1fludarabine 1Cyclophosphamide 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Microsatellite Instability × Gastrointestinal × 30 days × Clear all
NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

University of Pittsburgh

Phase 2 Active not recruiting
20 enrolled
DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

NCT07180966 2026-05-26

SAH

Ruijin Hospital

Completed
780 enrolled
Gastrointestinal

Postoperative Complications, Stomach Neoplasms, Microsatellite Instability

NCT06004245 2026-05-08

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

Vividion Therapeutics, Inc.

Phase 1 Recruiting
280 enrolled
Gastrointestinal

Colorectal Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡